178 related articles for article (PubMed ID: 9343306)
1. 3,5-Diiodo-L-thyronine (T2) has selective thyromimetic effects in vivo and in vitro.
Ball SG; Sokolov J; Chin WW
J Mol Endocrinol; 1997 Oct; 19(2):137-47. PubMed ID: 9343306
[TBL] [Abstract][Full Text] [Related]
2. 3,5-diiodo-L-thyronine stimulates type 1 5'deiodinase activity in rat anterior pituitaries in vivo and in reaggregate cultures and GH3 cells in vitro.
Baur A; Bauer K; Jarry H; Köhrle J
Endocrinology; 1997 Aug; 138(8):3242-8. PubMed ID: 9231774
[TBL] [Abstract][Full Text] [Related]
3. Effect of 3,5-diiodo-L-thyronine on thyroid stimulating hormone and growth hormone serum levels in hypothyroid rats.
Moreno M; Lombardi A; Lombardi P; Goglia F; Lanni A
Life Sci; 1998; 62(26):2369-77. PubMed ID: 9651103
[TBL] [Abstract][Full Text] [Related]
4. 3,5-Diiodo-L-thyronine (3,5-t2) exerts thyromimetic effects on hypothalamus-pituitary-thyroid axis, body composition, and energy metabolism in male diet-induced obese mice.
Jonas W; Lietzow J; Wohlgemuth F; Hoefig CS; Wiedmer P; Schweizer U; Köhrle J; Schürmann A
Endocrinology; 2015 Jan; 156(1):389-99. PubMed ID: 25322465
[TBL] [Abstract][Full Text] [Related]
5. Effects of tri-iodothyronine, thyroxine and isopropyl-di-iodothyronine on thyroid-stimulating hormone in serum and pituitary gland and on pituitary concentrations of prolactin, growth hormone, luteinizing hormone and follicle-stimulating hormone in hypothyroid rats.
Wong CC; Döhler KD; von zur Mühlen A
J Endocrinol; 1980 Nov; 87(2):255-63. PubMed ID: 6776220
[TBL] [Abstract][Full Text] [Related]
6. 3'-Acetyl-3,5-diiodo-L-thyronine: a novel highly active thyromimetic with low receptor affinity.
Benson MG; Ellis D; Emmett JC; Leeson PD; Pearce NJ; Shah VP; Underwood AH
Biochem Pharmacol; 1984 Oct; 33(20):3143-9. PubMed ID: 6091671
[TBL] [Abstract][Full Text] [Related]
7. Deletion of the thyroid hormone beta1 receptor increases basal and triiodothyronine-induced growth hormone messenger ribonucleic acid in GH3 cells.
Ball SG; Ikeda M; Chin WW
Endocrinology; 1997 Aug; 138(8):3125-32. PubMed ID: 9231759
[TBL] [Abstract][Full Text] [Related]
8. Quantitative analysis of DNA binding affinity and dimerization properties of wild-type and mutant thyroid hormone receptor beta1.
Takeda T; Nagasawa T; Miyamoto T; Minemura K; Hashizume K; Degroot LJ
Thyroid; 2000 Jan; 10(1):11-8. PubMed ID: 10691308
[TBL] [Abstract][Full Text] [Related]
9. Differential regulation of thyroid hormone receptor messenger ribonucleic acid levels by thyrotropin-releasing hormone.
Jones KE; Chin WW
Endocrinology; 1991 Apr; 128(4):1763-8. PubMed ID: 1900776
[TBL] [Abstract][Full Text] [Related]
10. Recovery of serum TSH and thyroid hormones after 3'isopropyl-3,5-diiodo-L-thyronine (DIIP) treatment: absence of inhibiting effect of bromocriptine on TSH secretion and evidence for autoregulation of serum T3 levels.
Salomon-Montavon NA; Burger AG
J Endocrinol Invest; 1984 Oct; 7(5):501-5. PubMed ID: 6439772
[TBL] [Abstract][Full Text] [Related]
11. Differential Effects of 3,5-Diiodo-L-Thyronine and 3,5,3'-Triiodo-L-Thyronine On Mitochondrial Respiratory Pathways in Liver from Hypothyroid Rats.
Silvestri E; Lombardi A; Coppola M; Gentile A; Cioffi F; Senese R; Goglia F; Lanni A; Moreno M; de Lange P
Cell Physiol Biochem; 2018; 47(6):2471-2483. PubMed ID: 29990992
[TBL] [Abstract][Full Text] [Related]
12. 3,5-Di-iodo-L-thyronine suppresses TSH in rats in vivo and in rat pituitary fragments in vitro.
Horst C; Harneit A; Seitz HJ; Rokos H
J Endocrinol; 1995 May; 145(2):291-7. PubMed ID: 7616162
[TBL] [Abstract][Full Text] [Related]
13. 3,5-diiodo-L-thyronine regulates glucose-6-phosphate dehydrogenase activity in the rat.
Lombardi A; Beneduce L; Moreno M; Diano S; Colantuoni V; Ursini MV; Lanni A; Goglia F
Endocrinology; 2000 May; 141(5):1729-34. PubMed ID: 10803583
[TBL] [Abstract][Full Text] [Related]
14. 3,5-di-iodothyronine stimulates tilapia growth through an alternate isoform of thyroid hormone receptor β1.
Navarrete-Ramírez P; Luna M; Valverde-R C; Orozco A
J Mol Endocrinol; 2014 Feb; 52(1):1-9. PubMed ID: 24031088
[TBL] [Abstract][Full Text] [Related]
15. Rapid stimulation in vitro of rat liver cytochrome oxidase activity by 3,5-diiodo-L-thyronine and by 3,3'-diiodo-L-thyronine.
Lanni A; Moreno M; Lombardi A; Goglia F
Mol Cell Endocrinol; 1994 Feb; 99(1):89-94. PubMed ID: 8187965
[TBL] [Abstract][Full Text] [Related]
16. Comparison of inhibitory effects of 3,5,3'-triiodothyronine (T3), thyroxine (T4), 3,3,',5'-triiodothyronine (rT3), and 3,3'-diiodothyronine (T2) on thyrotropin-releasing hormone-induced release of thyrotropin in the rat in vitro.
Chopra IJ; Carlson HE; Solomon DH
Endocrinology; 1978 Aug; 103(2):393-402. PubMed ID: 105890
[TBL] [Abstract][Full Text] [Related]
17. Thyroid hormone analogues. Synthesis of 3'-substituted 3,5-diiodo-L-thyronines and quantitative structure-activity studies of in vitro and in vivo thyromimetic activities in rat liver and heart.
Leeson PD; Ellis D; Emmett JC; Shah VP; Showell GA; Underwood AH
J Med Chem; 1988 Jan; 31(1):37-54. PubMed ID: 3336030
[TBL] [Abstract][Full Text] [Related]
18. DNA binding affinity of hTRbeta1 mutants as heterodimers with traps from different tissues.
Takeda T; Suzuki S; Nagasawa T; Liu RT; DeGroot LJ
Biochimie; 1999 Apr; 81(4):297-308. PubMed ID: 10401662
[TBL] [Abstract][Full Text] [Related]
19. Intracellular and plasma membrane-initiated pathways involved in the [Ca2+]i elevations induced by iodothyronines (T3 and T2) in pituitary GH3 cells.
Del Viscovo A; Secondo A; Esposito A; Goglia F; Moreno M; Canzoniero LM
Am J Physiol Endocrinol Metab; 2012 Jun; 302(11):E1419-30. PubMed ID: 22414808
[TBL] [Abstract][Full Text] [Related]
20. Sodium butyrate selectively alters thyroid hormone receptor gene expression in GH3 cells.
Lazar MA
J Biol Chem; 1990 Oct; 265(29):17474-7. PubMed ID: 2211641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]